PLAY PODCASTS
The chemical immunology revolution
Season 2 · Episode 11

The chemical immunology revolution

In this final episode of Season 2 you’ll meet Dr. Lingyin Li and learn about her disruptive work aiming to overcome traditional cancer therapeutic approaches. Her studies of the cGAMP cascade pathway are leading to ways to use chemistry to activate our own immune systems to fight cancer in a new way. As always, you get a great mix of an intriguing personal story and world-class science!

Bringing Chemistry to Life · Paolo Braiuca, Lingyin Li

October 20, 202130m 24s

Show Notes

Visit https://thermofisher.com/bctl to register for your free Bringing Chemistry to Life T-shirt and https://www.alfa.com/en/chemistry-podcasts/ to access our episode summary sheet, which contains links to recent publications and additional content recommendations for our guest.

Dr. Lingyin Li is strong and determined and smart and brave. She knows that what doesn’t kill you makes you stronger and that challenges are just steps towards success. While she survived her fight with cancer, many people don’t. Her biochemistry research, however, is as brave as she is and offers the promise to revolutionize cancer treatment. This new way of thinking overcomes the limitations of the two main therapeutic approaches: the general toxicity of chemotherapy and the drug resistance of targeted therapy.

Lingying’s study of the cGAMP cascade is as new as it is disruptive, offering a completely new perspective on how we could use chemistry to activate our own immune system. This is opening the door to a completely novel approach to the use of immunotherapy as a targeted treatment for cancer and viral infections.

This interview is another great example of chemistry research defining new ways in an adjacent scientific discipline and, as it often happens in this podcast, an intriguing personal story. A perfect finale to close this exciting season 2 of Bringing Chemistry to Life, and a hint of more of what’s to come in our next season.

We read every email so please share your questions and feedback with us! 

Topics

cancerdmxaachemical immunologyviruscgampchemotherapyviral infectionspathwaybiochemistryenpp1stingimmunology